One surprising pattern is a drop in daily steps and exercise after starting these medications. Lower movement can happen for many reasons: appetite shifts, energy changes, or altered muscle composition. Because these drugs may reduce both fat and muscle, less activity could make it harder to keep strength and mobility over time, especially as people age.
That raises practical questions about how to combine medication with strategies that protect muscle and function. Can small changes in daily routines, targeted resistance work, or guided physical-activity plans preserve gains? The paper points toward solutions worth learning about, and exploring them could help people use these treatments in ways that support long-term vitality and inclusivity for all bodies.
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data found that daily step counts and exercise levels dropped after people started these medications, despite successful weight loss. Because the drugs can reduce muscle mass along with fat, the decline in physical activity raises concerns about preserving strength and long-term health.
